Cargando…
Treatment Adherence and Clinical Outcomes of Patients with Inflammatory Bowel Disease on Biological Agents During the SARS-CoV-2 Pandemic
BACKGROUND: The outbreak of COVID19 evolved rapidly into a global pandemic, forcing hospitals, including inflammatory bowel disease (IBD) referral units, to change their practices to ensure quality of care. AIMS: To describe the clinical outcomes and the fulfilment of the treatment schedule of patie...
Autores principales: | Iborra, Ignacio, Puig, Maria, Marín, Laura, Calafat, Margalida, Cañete, Fiorella, Quiñones, Carles, González-González, Laura, Cardona, Glòria, Mañosa, Míriam, Domènech, Eugeni |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7814978/ https://www.ncbi.nlm.nih.gov/pubmed/33469807 http://dx.doi.org/10.1007/s10620-020-06807-0 |
Ejemplares similares
-
Editorial: Postoperative management of Crohn's disease: One size does not fit all
por: Domènech, Eugeni, et al.
Publicado: (2023) -
Impact of immunosuppressants on SARS-CoV-2 infection in elderly patients with inflammatory bowel disease
por: Calafat, Margalida, et al.
Publicado: (2021) -
Antitumor Necrosis Factor Agents to Treat Endoscopic Postoperative Recurrence of Crohn's Disease: A Nationwide Study With Propensity-Matched Score Analysis
por: Cañete, Fiorella, et al.
Publicado: (2020) -
Optimizing post-operative Crohn’s disease treatment
por: Domènech, Eugeni, et al.
Publicado: (2014) -
Clinical Presentation, Management, and Evolution of Lymphomas in Patients with Inflammatory Bowel Disease: An ENEIDA Registry Study
por: Guerra, Ivan, et al.
Publicado: (2023)